PakC.Y.C.Role of medical prevention. J Urol1989; 141: 798.
2.
PakC.Y.C., BrittonF., PetersonR.Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria. Am J Med1980; 69: 19.
3.
SmithC.L.When should the stone patient be evaluated? Early evaluation of single stone formers. Med Clin North Am1984; 68: 455.
4.
WilsonD.M.Clinical and laboratory approaches for evaluation of neprholithiasis. J Urol1989; 141: 770.
5.
JohnsonC.M., WilsonD.M., O'FallonW.M.Renal stone epidemiology. A 25 year study in Rochester, Minnesota. Kidney Int1979; 16: 624.
6.
WilliamsR.E.Long term survey of 538 patients with upper urinary tract stone. Br J Urol1963; 35: 416.
7.
StraussA.L., CoeF.L., ParksJ.H.Formation of a single calcium stone of renal origin. Clincal and laboratory characteristics in patients. Arch Intern Med1982; 142: 504.
8.
PakC.Y.C.Should patients with single renal stone occorrence undergo diagnostic evaluation?J Urol1982; 127: 855.
9.
PakC.Y.C., PetersP., HurtG.Is selective therapy of recurrent nephrolithiasis possible. Am J Med1981; 71: 615.
10.
HoskingD., EricksonS.B., van den BergC.J.The stone clinic effect in patients with idiopathic calcium urolithiasis. J Urol1983; 130: 1115.
11.
BaggioB., GambaroG.An inheritable anomaly of red-cell oxalate transport in “primary” calcium nephrolithiasis correctable with diuretics. N Engl J Med1986; 314: 599.
12.
GambaroG., MarchiniF., VincentiM.Clinical features of idiopathic calium-oxalate nephrolithiasis associated with the anomalous erythrocyte self-exchange of oxalate. PRoc. 5th Eur Urolithiasis Symp, Manchester, 1994; 21-23 April: 67.
